Use cases, best practice and reporting standards for metabolomics in regulatory toxicology

Lack of best practice guidelines currently limits the application of metabolomics in the regulatory sciences. Here, the MEtabolomics standaRds Initiative in Toxicology (MERIT) proposes methods and reporting standards for several important applications of metabolomics in regulatory toxicology.

Guardado en:
Detalles Bibliográficos
Autores principales: Mark R. Viant, Timothy M. D. Ebbels, Richard D. Beger, Drew R. Ekman, David J. T. Epps, Hennicke Kamp, Pim E. G. Leonards, George D. Loizou, James I. MacRae, Bennard van Ravenzwaay, Philippe Rocca-Serra, Reza M. Salek, Tilmann Walk, Ralf J. M. Weber
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/4701db2695034f70a507e741b7841422
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4701db2695034f70a507e741b7841422
record_format dspace
spelling oai:doaj.org-article:4701db2695034f70a507e741b78414222021-12-02T15:35:49ZUse cases, best practice and reporting standards for metabolomics in regulatory toxicology10.1038/s41467-019-10900-y2041-1723https://doaj.org/article/4701db2695034f70a507e741b78414222019-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-10900-yhttps://doaj.org/toc/2041-1723Lack of best practice guidelines currently limits the application of metabolomics in the regulatory sciences. Here, the MEtabolomics standaRds Initiative in Toxicology (MERIT) proposes methods and reporting standards for several important applications of metabolomics in regulatory toxicology.Mark R. ViantTimothy M. D. EbbelsRichard D. BegerDrew R. EkmanDavid J. T. EppsHennicke KampPim E. G. LeonardsGeorge D. LoizouJames I. MacRaeBennard van RavenzwaayPhilippe Rocca-SerraReza M. SalekTilmann WalkRalf J. M. WeberNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Mark R. Viant
Timothy M. D. Ebbels
Richard D. Beger
Drew R. Ekman
David J. T. Epps
Hennicke Kamp
Pim E. G. Leonards
George D. Loizou
James I. MacRae
Bennard van Ravenzwaay
Philippe Rocca-Serra
Reza M. Salek
Tilmann Walk
Ralf J. M. Weber
Use cases, best practice and reporting standards for metabolomics in regulatory toxicology
description Lack of best practice guidelines currently limits the application of metabolomics in the regulatory sciences. Here, the MEtabolomics standaRds Initiative in Toxicology (MERIT) proposes methods and reporting standards for several important applications of metabolomics in regulatory toxicology.
format article
author Mark R. Viant
Timothy M. D. Ebbels
Richard D. Beger
Drew R. Ekman
David J. T. Epps
Hennicke Kamp
Pim E. G. Leonards
George D. Loizou
James I. MacRae
Bennard van Ravenzwaay
Philippe Rocca-Serra
Reza M. Salek
Tilmann Walk
Ralf J. M. Weber
author_facet Mark R. Viant
Timothy M. D. Ebbels
Richard D. Beger
Drew R. Ekman
David J. T. Epps
Hennicke Kamp
Pim E. G. Leonards
George D. Loizou
James I. MacRae
Bennard van Ravenzwaay
Philippe Rocca-Serra
Reza M. Salek
Tilmann Walk
Ralf J. M. Weber
author_sort Mark R. Viant
title Use cases, best practice and reporting standards for metabolomics in regulatory toxicology
title_short Use cases, best practice and reporting standards for metabolomics in regulatory toxicology
title_full Use cases, best practice and reporting standards for metabolomics in regulatory toxicology
title_fullStr Use cases, best practice and reporting standards for metabolomics in regulatory toxicology
title_full_unstemmed Use cases, best practice and reporting standards for metabolomics in regulatory toxicology
title_sort use cases, best practice and reporting standards for metabolomics in regulatory toxicology
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/4701db2695034f70a507e741b7841422
work_keys_str_mv AT markrviant usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT timothymdebbels usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT richarddbeger usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT drewrekman usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT davidjtepps usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT hennickekamp usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT pimegleonards usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT georgedloizou usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT jamesimacrae usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT bennardvanravenzwaay usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT philipperoccaserra usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT rezamsalek usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT tilmannwalk usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
AT ralfjmweber usecasesbestpracticeandreportingstandardsformetabolomicsinregulatorytoxicology
_version_ 1718386408616361984